ChromaDex Corporation (CDXC) Financials
CDXC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 55.0 million | 26.5 million |
2023-09-30 | 53.5 million | 26.2 million |
2023-06-30 | 53.2 million | 26.0 million |
2023-03-31 | 53.8 million | 25.8 million |
CDXC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 553000 | 1.0 million |
2023-09-30 | 370000 | 1.1 million |
2023-06-30 | 3.3 million | 1.3 million |
2023-03-31 | 2.7 million | 1.3 million |
CDXC Net Income
No data available :(
CDXC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 27.3 million | - | 3.3 million |
2023-09-30 | 26.6 million | - | 3.8 million |
2023-06-30 | 26.3 million | - | 3.9 million |
2023-03-31 | 23.1 million | - | 4.1 million |
CDXC Shares Outstanding
CDXC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 21000 | 1.2 million | 5.4 million | 6.5 million |
2023-09-30 | 26000 | 1.2 million | 5.8 million | 6.0 million |
2023-06-30 | 10000 | 1.4 million | 7.3 million | 6.0 million |
2023-03-31 | 91000 | 1.2 million | 6.4 million | 7.9 million |
CDXC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 21.2 million | 8.3 million |
2023-09-30 | 19.5 million | 7.5 million |
2023-06-30 | 20.3 million | 8.0 million |
2023-03-31 | 22.6 million | 9.0 million |
CDXC
Price: $3.78
52 week price:
Earnings Per Share: -0.07 USD
P/E Ratio: -16.89
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 333600
Ebitda: -3.0 millionMarket Capitalization: 299.7 million